Drug Database
Back to search

United States· US:71205-577_d8a5e670-a721-42c1-a384-4efe056f3a65

Bicalutamide

A bicalutamide product containing bicalutamide, registered in United States by Proficient Rx LP. The same ATC class is registered in 18 of our 19 countries.

ATC L02BB03US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedBicalutamideATCL02BB03REGISTER NO.US:71205-577_d8a5e670…PACKS LISTED6CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about bicalutamideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Bicalutamide is registered in 18 of 19 countries.

Countries holding a registration under ATC L02BB03 (bicalutamide), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 11 of them publish a price we can compare per daily dose
Search bicalutamide products by name

Bicalutamide · ATC L02BB03

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of bicalutamide costs, country by country.

Normalised to the WHO defined daily dose (50 mg), the median price runs from $1.21 in Italy to $2.29 in Switzerland — a ×1.9 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Bicalutamide · price per daily dose (50 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$2.29
  • ES Spain$1.61
  • FR France$1.42
  • IT Italy$1.21
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
BICALUTAMIDE
Manufacturer
Proficient Rx LP
Country
United States (US)
ATC code
L02BB03
ATC class
Bicalutamide
Defined daily dose
50 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 6

  • ndc11
    7120557730
    30 TABLET in 1 BOTTLE (71205-577-30)
  • ndc11
    7120557760
    60 TABLET in 1 BOTTLE (71205-577-60)
  • ndc11
    7120557790
    90 TABLET in 1 BOTTLE (71205-577-90)
  • ndc11
    71205-577-30
  • ndc11
    71205-577-60
  • ndc11
    71205-577-90

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

477 interactions on record for bicalutamide.

Graded by severity as the source publishes them — 82 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check bicalutamide against other medicinesHow interaction checks work

Bicalutamide · interactions on record

477 records

  • 82 severe
  • 302 moderate
  • 15 minor
  • 78 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • LonafarnibA16AX20severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Bicalutamide in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bicalutamide products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Androbloc, Bicalutamid +pharma
  • Belgium · Bicalutamide Eg, Bicalutamide Sandoz
  • Bulgaria · Бикагратис, Бикалутамид Акорд
  • Cyprus · Bicalutamide Rafarm, Bikalen
  • Czechia · Bicaluplex, Bicalutanorm
  • Germany · Bicadex, Bicalut
  • Denmark · Bicalustad, Bicalutamid Bluefish
  • Estonia · Bicalutamide Accord, Bicalutamide Teva
  • Spain · Bicalutamida Accord, Bicalutamida Almus
  • Finland · Bicalutamid Orion, Bicalutamide Accord
  • France · Bicalutamide Accord, Bicalutamide Almus
  • United Kingdom (Northern Ireland) · Bicalutamide, Bicalutamide Accord Healthcare
  • Greece · Bicalut, Bicalutamide Rafarm
  • Croatia · Bicaprox, Bikalis
  • Hungary · Bicalutamide Pharmacenter, Bilutamid
  • Ireland · Bicalutamide Accord, Bicalutamide Fair-Med
  • Iceland · Bicalutamid Medical, Bicalutamide Accord
  • Italy · Bicalutamide Accord, Bicalutamide Ahcl
  • Lithuania · Bicalutamide Accord, Bicalutamide Teva
  • Luxembourg · Bicalutamide Eg, Bicalutamide Teva
  • Latvia · Bicalutamide Accord, Bicalutamide Teva
  • Malta · Bicalutamide Pharmacare
  • Netherlands · Bicalutamide Accord, Bicalutamide Aurobindo
  • Norway · Bicalutamide Accord, Bicalutamide Bluefish
  • Poland · Bicalutamide Accord, Binabic
  • Portugal · Bicalutamida Accord, Bicalutamida Aurobindo
  • Romania · Bicalutamida Accord, Bicalutamidă Accord
  • Sweden · Bicalustad, Bicalutamid Sandoz
  • Slovenia · Bikalutamid Accord, Bikalutamid Lek
  • Slovakia · Bicagelan, Bicalutamid Teva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d6bbe887-24df-4ca4-bf28-5f4ad4a6dd26
GET /v1/drugs/d6bbe887-24df-4ca4-bf28-5f4ad4a6dd26?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "50",
  "substance": "BICALUTAMIDE",
  "productndc": "71205-577",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA078917",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about bicalutamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console